Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zetia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

Schering-Plough sales double on statins

Schering-Plough's Q3 FY07 earnings double on soaring sales of its statin products Vytorin and Zetia. ... The campaign revealed how the combination of Zetia (ezetimibe) and Merck &Co's Zocor (simvastatin) in Vytorin helped to lower cholesterol.

Pharma news in brief

cholesterol-reducing product in the £11bn marketplace when combined with Zetia, made by Schering-Plough (SP). ... SP already sells a Zetia-Zocor (Pfizer) combination, made by Merck.

Pharma news in brief

Vytorin and Zetia sales boost Schering-Plough and Merck profits. First-quarter profits at Schering-Plough (S-P) and Merck have risen on the back of increased sales of two drugs ... Combined sales of cholesterol-lowering drugs, Vytorin and Zetia rose 54

Merck profits rise on Gardasil and Januvia

Statins sales up 26 per cent. Revenue from statins Vytorin and Zetia, which Merck markets along with Schering-Plough (S-P), rose an impressive 26 per cent to reach USD ... Vytorin is a combination of Zetia and Zocor, which attacks cholesterol produced in

US pharma turning the corner

S-P's cholesterol treatment, Vytorin, which combines its drug Zetia with Merck's Zocor, is not counted in the firm's sales because of accounting rules; the two companies share

[ Previous 5 results ] 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics